Compare TFX & CWAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TFX | CWAN |
|---|---|---|
| Founded | 1943 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 5.3B |
| IPO Year | N/A | 2021 |
| Metric | TFX | CWAN |
|---|---|---|
| Price | $122.52 | $22.41 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 10 | 9 |
| Target Price | ★ $139.88 | $30.67 |
| AVG Volume (30 Days) | 757.6K | ★ 5.6M |
| Earning Date | 11-06-2025 | 11-05-2025 |
| Dividend Yield | ★ 1.09% | N/A |
| EPS Growth | N/A | ★ 46826.67 |
| EPS | N/A | ★ 1.40 |
| Revenue | ★ $3,189,988,000.00 | $640,376,000.00 |
| Revenue This Year | $9.90 | $64.92 |
| Revenue Next Year | $10.51 | $29.34 |
| P/E Ratio | ★ N/A | $15.68 |
| Revenue Growth | 5.42 | ★ 50.91 |
| 52 Week Low | $102.58 | $15.74 |
| 52 Week High | $185.94 | $32.00 |
| Indicator | TFX | CWAN |
|---|---|---|
| Relative Strength Index (RSI) | 53.38 | 64.08 |
| Support Level | $123.66 | $21.14 |
| Resistance Level | $127.88 | $22.14 |
| Average True Range (ATR) | 3.89 | 0.73 |
| MACD | 0.38 | -0.04 |
| Stochastic Oscillator | 39.53 | 93.27 |
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.
Clearwater Analytics describes its mission as aiming to be the world's most trusted and comprehensive technology platform for the entire investment cycle. Clearwater has historically focused on back-office functions such as investment accounting, but with acquisitions such Enfusion, Beacon, and Bistro, the firm has broadened its focus with front-office and middle-office capabilities. Clearwater primarily serves insurance companies, asset managers, hedge funds, and corporate treasuries. Pro forma for Enfusion, about 76% of Clearwater's revenue is generated in the US.